National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings, 76632-76633 [2013-30009]

Download as PDF 76632 Federal Register / Vol. 78, No. 243 / Wednesday, December 18, 2013 / Notices TABLE 1—ESTIMATED ANNUALIZED BURDEN HOURS FOR VANGUARD (PILOT) STUDY RESPONDENTS, STUDY VISITS THROUGH 60 MONTHS OF AGE OF THE CHILD—Continued Data collection activity Estimated number of respondents Type of respondent Child-Focused Physical Measures—Anthropometry, Blood Pressure, Vision Screening, Lung Function, & Motor Skills (6M, 12M, 24M, 36M, 48M, 60M). Estimated number of responses per respondent Average burden per response (in hrs) Estimated total annual burden hours Child ................................................. 1,217 2 9/60 365 Primary Caregiver ............................ Primary Caregiver ............................ 935 1,085 13 13 41/60 8/60 8,375 1,775 Primary Caregiver ............................ Primary Caregiver ............................ Primary Caregiver ............................ Primary Caregiver ............................ Child ................................................. Primary Caregiver ............................ Biological Mother, Biological Father Primary Caregiver ............................ Primary Caregiver ............................ Primary Caregiver ............................ Child ................................................. 562 1,046 1,286 1,711 1,711 1,364 1,364 1,380 1,431 1,332 1,332 1 1 1 1 1 1 1 1 1 1 1 40/60 26/60 50/60 61/60 22/60 32/60 15/60 89/60 23/60 46/60 22/60 375 453 1,072 1,740 627 728 341 2,047\ 549 1,021 488 Primary Caregiver ............................ Primary Caregiver ............................ 200 67 2 2 17/60 7/60 113 16 Primary Caregiver ............................ 200 3 43/60 430 Total Vanguard (Pilot) Study .......................................................... ........................ ........................ ........................ 48,567 Total Formative Research .. .......................................................... ........................ ........................ ........................ 2,835 Environmental Sample Collection—Vacuum Bag Dust, Indoor and Outdoor Visual Observations, & Dust Wipes (12M, 36M, 48M, 60M). 18-Month Interview .................... 24-Month Interview .................... 30-Month Interview .................... 36-Month Interview .................... 42-Month Interview .................... 48-Month Interview .................... 54-Month Interview .................... 60-Month Interview .................... Subsample Studies: Noise (36M, 60M) ...................... Bioelectrical Impedance Analysis (BIA) (48M, 60M). Physical Activity (Accelerometer) (36M, 48M, 60M). Dated: December 6, 2013. Sarah L. Glavin, Deputy Director, Office of Science Policy, Analysis, and Communications, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. [FR Doc. 2013–30091 Filed 12–17–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health ehiers on DSK2VPTVN1PROD with NOTICES National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose VerDate Mar<15>2010 15:27 Dec 17, 2013 Jkt 232001 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Low-Dose CT Imaging (UO1). Date: February 26, 2014. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, DEM II, Suite 951, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Suite 959, Bethesda, MD 20892, 301–451–3398, hayesj@ mail.nih.gov. Dated: December 12, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–30012 Filed 12–17–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose E:\FR\FM\18DEN1.SGM 18DEN1 Federal Register / Vol. 78, No. 243 / Wednesday, December 18, 2013 / Notices ehiers on DSK2VPTVN1PROD with NOTICES confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council. Date: February 5, 2014. Open: 8:30 a.m. to 12:00 p.m. Agenda: To present the Director’s Report and other scientific presentations. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Closed: 4:15 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Digestive Diseases and Nutrition Subcommittee. Date: February 5, 2014. Open: 1:00 p.m. to 2:30 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Closed: 2:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Diabetes, Endocrinology and Metabolic Diseases Subcommittee. Date: February 5, 2014. Open: 1:00 p.m. to 2:30 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference 10, 31 Center Drive, Bethesda, MD 20892. Closed: 2:30 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference 10, 31 Center Drive, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, VerDate Mar<15>2010 15:27 Dec 17, 2013 Jkt 232001 National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases Subcommittee. Date: February 5, 2014. Open: 1:00 p.m. to 3:00 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892. Closed: 3:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C Wing, 6th Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892. Contact Person: Brent B. Stanfield, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, Bethesda, MD 20892, (301) 594–8843, stanfibr@niddk.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.niddk.nih.gov/fund/divisions/DEA/ Council/coundesc.htm., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: December 12, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–30009 Filed 12–17–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 76633 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the National Advisory Neurological Disorders and Stroke Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: January 30–31, 2014. Open: January 30, 2014, 8:00 a.m. to 3:00 p.m. Agenda: Report by the Director, NINDS; Report by the Associate Director for Extramural Research; and Administrative and Program Developments. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: January 30, 2014, 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: January 31, 2014, 8:00 a.m. to 11:00 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Robert Finkelstein, Ph.D., Associate Director for Extramural Research, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301) 496–9248. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on E:\FR\FM\18DEN1.SGM 18DEN1

Agencies

[Federal Register Volume 78, Number 243 (Wednesday, December 18, 2013)]
[Notices]
[Pages 76632-76633]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30009]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Diabetes and Digestive and Kidney Diseases Advisory Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose

[[Page 76633]]

confidential trade secrets or commercial property such as patentable 
material, and personal information concerning individuals associated 
with the grant applications, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council.
    Date: February 5, 2014.
    Open: 8:30 a.m. to 12:00 p.m.
    Agenda: To present the Director's Report and other scientific 
presentations.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 4:15 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Digestive Diseases and Nutrition 
Subcommittee.
    Date: February 5, 2014.
    Open: 1:00 p.m. to 2:30 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Diabetes, Endocrinology and Metabolic 
Diseases Subcommittee.
    Date: February 5, 2014.
    Open: 1:00 p.m. to 2:30 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference 10, 31 Center Drive, Bethesda, MD 20892.
    Closed: 2:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.

    Name of Committee: National Diabetes and Digestive and Kidney 
Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases 
Subcommittee.
    Date: February 5, 2014.
    Open: 1:00 p.m. to 3:00 p.m.
    Agenda: To review the Division's scientific and planning 
activities.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Closed: 3:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, C Wing, 6th 
Floor, Conference Room 7, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Brent B. Stanfield, Ph.D., Director, Division of 
Extramural Activities, National Institutes of Diabetes and Digestive 
and Kidney Diseases, 6707 Democracy Blvd. Room 715, MSC 5452, 
Bethesda, MD 20892, (301) 594-8843, stanfibr@niddk.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm., 
where an agenda and any additional information for the meeting will 
be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: December 12, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-30009 Filed 12-17-13; 8:45 am]
BILLING CODE 4140-01-P